VEGFR-1 antagonists and PlGF have great therapeutic potential

Gespeichert in:

Format:	E-Artikel
Sprache:	Englisch

Erschienen:	2002

Schlagwörter:	Vascular Endothelial Growth Factor Vascular Endothelial Growth Factor Expression Bone Marrow Suppression Haematopoietic Stem Cell Nature Medicine

Anmerkung:	© Adis International Ltd 2002

Übergeordnetes Werk:	Enthalten in: Inpharma weekly - Auckland : ADIS internat., 1975, 1354(2002), 1 vom: Sept., Seite 7-7
Übergeordnetes Werk:	volume:1354 ; year:2002 ; number:1 ; month:09 ; pages:7-7

Links:	Volltext

DOI / URN:	10.2165/00128413-200213540-00013

Katalog-ID:	SPR03513786X

Internformat


LEADER	01000caa a22002652 4500
001	SPR03513786X
003	DE-627
005	20230519203420.0
007	cr uuu---uuuuu
008	201007s2002 xx \|\|\|\|\|o 00\| \|\|eng c
024	7		\|a 10.2165/00128413-200213540-00013 \|2 doi
035			\|a (DE-627)SPR03513786X
035			\|a (SPR)00128413-200213540-00013-e
040			\|a DE-627 \|b ger \|c DE-627 \|e rakwb
041			\|a eng
245	1	0	\|a VEGFR-1 antagonists and PlGF have great therapeutic potential
264		1	\|c 2002
336			\|a Text \|b txt \|2 rdacontent
337			\|a Computermedien \|b c \|2 rdamedia
338			\|a Online-Ressource \|b cr \|2 rdacarrier
500			\|a © Adis International Ltd 2002
650		4	\|a Vascular Endothelial Growth Factor \|7 (dpeaa)DE-He213
650		4	\|a Vascular Endothelial Growth Factor Expression \|7 (dpeaa)DE-He213
650		4	\|a Bone Marrow Suppression \|7 (dpeaa)DE-He213
650		4	\|a Haematopoietic Stem Cell \|7 (dpeaa)DE-He213
650		4	\|a Nature Medicine \|7 (dpeaa)DE-He213
773	0	8	\|i Enthalten in \|t Inpharma weekly \|d Auckland : ADIS internat., 1975 \|g 1354(2002), 1 vom: Sept., Seite 7-7 \|w (DE-627)373977859 \|w (DE-600)2127607-9 \|x 2230-6056 \|7 nnns
773	1	8	\|g volume:1354 \|g year:2002 \|g number:1 \|g month:09 \|g pages:7-7
856	4	0	\|u https://dx.doi.org/10.2165/00128413-200213540-00013 \|z lizenzpflichtig \|3 Volltext
912			\|a GBV_USEFLAG_A
912			\|a SYSFLAG_A
912			\|a GBV_SPRINGER
912			\|a SSG-OLC-PHA
912			\|a GBV_ILN_20
951			\|a AR
952			\|d 1354 \|j 2002 \|e 1 \|c 09 \|h 7-7

Indexfelder

matchkey_str	article:22306056:2002----::ef1naoitadlfaeratea
hierarchy_sort_str	2002
publishDate	2002
allfields	10.2165/00128413-200213540-00013 doi (DE-627)SPR03513786X (SPR)00128413-200213540-00013-e DE-627 ger DE-627 rakwb eng VEGFR-1 antagonists and PlGF have great therapeutic potential 2002 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 2002 Vascular Endothelial Growth Factor (dpeaa)DE-He213 Vascular Endothelial Growth Factor Expression (dpeaa)DE-He213 Bone Marrow Suppression (dpeaa)DE-He213 Haematopoietic Stem Cell (dpeaa)DE-He213 Nature Medicine (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 1354(2002), 1 vom: Sept., Seite 7-7 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:1354 year:2002 number:1 month:09 pages:7-7 https://dx.doi.org/10.2165/00128413-200213540-00013 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 AR 1354 2002 1 09 7-7
spelling	10.2165/00128413-200213540-00013 doi (DE-627)SPR03513786X (SPR)00128413-200213540-00013-e DE-627 ger DE-627 rakwb eng VEGFR-1 antagonists and PlGF have great therapeutic potential 2002 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 2002 Vascular Endothelial Growth Factor (dpeaa)DE-He213 Vascular Endothelial Growth Factor Expression (dpeaa)DE-He213 Bone Marrow Suppression (dpeaa)DE-He213 Haematopoietic Stem Cell (dpeaa)DE-He213 Nature Medicine (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 1354(2002), 1 vom: Sept., Seite 7-7 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:1354 year:2002 number:1 month:09 pages:7-7 https://dx.doi.org/10.2165/00128413-200213540-00013 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 AR 1354 2002 1 09 7-7
allfields_unstemmed	10.2165/00128413-200213540-00013 doi (DE-627)SPR03513786X (SPR)00128413-200213540-00013-e DE-627 ger DE-627 rakwb eng VEGFR-1 antagonists and PlGF have great therapeutic potential 2002 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 2002 Vascular Endothelial Growth Factor (dpeaa)DE-He213 Vascular Endothelial Growth Factor Expression (dpeaa)DE-He213 Bone Marrow Suppression (dpeaa)DE-He213 Haematopoietic Stem Cell (dpeaa)DE-He213 Nature Medicine (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 1354(2002), 1 vom: Sept., Seite 7-7 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:1354 year:2002 number:1 month:09 pages:7-7 https://dx.doi.org/10.2165/00128413-200213540-00013 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 AR 1354 2002 1 09 7-7
allfieldsGer	10.2165/00128413-200213540-00013 doi (DE-627)SPR03513786X (SPR)00128413-200213540-00013-e DE-627 ger DE-627 rakwb eng VEGFR-1 antagonists and PlGF have great therapeutic potential 2002 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 2002 Vascular Endothelial Growth Factor (dpeaa)DE-He213 Vascular Endothelial Growth Factor Expression (dpeaa)DE-He213 Bone Marrow Suppression (dpeaa)DE-He213 Haematopoietic Stem Cell (dpeaa)DE-He213 Nature Medicine (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 1354(2002), 1 vom: Sept., Seite 7-7 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:1354 year:2002 number:1 month:09 pages:7-7 https://dx.doi.org/10.2165/00128413-200213540-00013 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 AR 1354 2002 1 09 7-7
allfieldsSound	10.2165/00128413-200213540-00013 doi (DE-627)SPR03513786X (SPR)00128413-200213540-00013-e DE-627 ger DE-627 rakwb eng VEGFR-1 antagonists and PlGF have great therapeutic potential 2002 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 2002 Vascular Endothelial Growth Factor (dpeaa)DE-He213 Vascular Endothelial Growth Factor Expression (dpeaa)DE-He213 Bone Marrow Suppression (dpeaa)DE-He213 Haematopoietic Stem Cell (dpeaa)DE-He213 Nature Medicine (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 1354(2002), 1 vom: Sept., Seite 7-7 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:1354 year:2002 number:1 month:09 pages:7-7 https://dx.doi.org/10.2165/00128413-200213540-00013 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 AR 1354 2002 1 09 7-7
language	English
source	Enthalten in Inpharma weekly 1354(2002), 1 vom: Sept., Seite 7-7 volume:1354 year:2002 number:1 month:09 pages:7-7
sourceStr	Enthalten in Inpharma weekly 1354(2002), 1 vom: Sept., Seite 7-7 volume:1354 year:2002 number:1 month:09 pages:7-7
format_phy_str_mv	Article
institution	findex.gbv.de
topic_facet	Vascular Endothelial Growth Factor Vascular Endothelial Growth Factor Expression Bone Marrow Suppression Haematopoietic Stem Cell Nature Medicine
isfreeaccess_bool	false
container_title	Inpharma weekly
publishDateDaySort_date	2002-09-01T00:00:00Z
hierarchy_top_id	373977859
id	SPR03513786X
language_de	englisch
fullrecord	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">SPR03513786X</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230519203420.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">201007s2002 xx \|\|\|\|\|o 00\| \|\|eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.2165/00128413-200213540-00013</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)SPR03513786X</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(SPR)00128413-200213540-00013-e</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">VEGFR-1 antagonists and PlGF have great therapeutic potential</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2002</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">© Adis International Ltd 2002</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Vascular Endothelial Growth Factor</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Vascular Endothelial Growth Factor Expression</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Bone Marrow Suppression</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Haematopoietic Stem Cell</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Nature Medicine</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">Inpharma weekly</subfield><subfield code="d">Auckland : ADIS internat., 1975</subfield><subfield code="g">1354(2002), 1 vom: Sept., Seite 7-7</subfield><subfield code="w">(DE-627)373977859</subfield><subfield code="w">(DE-600)2127607-9</subfield><subfield code="x">2230-6056</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:1354</subfield><subfield code="g">year:2002</subfield><subfield code="g">number:1</subfield><subfield code="g">month:09</subfield><subfield code="g">pages:7-7</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://dx.doi.org/10.2165/00128413-200213540-00013</subfield><subfield code="z">lizenzpflichtig</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_SPRINGER</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">1354</subfield><subfield code="j">2002</subfield><subfield code="e">1</subfield><subfield code="c">09</subfield><subfield code="h">7-7</subfield></datafield></record></collection>
ppnlink_with_tag_str_mv	@@773@@(DE-627)373977859
format	electronic Article
delete_txt_mv	keep
collection	springer
remote_str	true
illustrated	Not Illustrated
issn	2230-6056
topic_title	VEGFR-1 antagonists and PlGF have great therapeutic potential Vascular Endothelial Growth Factor (dpeaa)DE-He213 Vascular Endothelial Growth Factor Expression (dpeaa)DE-He213 Bone Marrow Suppression (dpeaa)DE-He213 Haematopoietic Stem Cell (dpeaa)DE-He213 Nature Medicine (dpeaa)DE-He213
topic	misc Vascular Endothelial Growth Factor misc Vascular Endothelial Growth Factor Expression misc Bone Marrow Suppression misc Haematopoietic Stem Cell misc Nature Medicine
spellingShingle	misc Vascular Endothelial Growth Factor misc Vascular Endothelial Growth Factor Expression misc Bone Marrow Suppression misc Haematopoietic Stem Cell misc Nature Medicine VEGFR-1 antagonists and PlGF have great therapeutic potential
topic_unstemmed	misc Vascular Endothelial Growth Factor misc Vascular Endothelial Growth Factor Expression misc Bone Marrow Suppression misc Haematopoietic Stem Cell misc Nature Medicine
topic_browse	misc Vascular Endothelial Growth Factor misc Vascular Endothelial Growth Factor Expression misc Bone Marrow Suppression misc Haematopoietic Stem Cell misc Nature Medicine
format_facet	Elektronische Aufsätze Aufsätze Elektronische Ressource
format_main_str_mv	Text Zeitschrift/Artikel
carriertype_str_mv	cr
hierarchy_parent_title	Inpharma weekly
hierarchy_parent_id	373977859
hierarchy_top_title	Inpharma weekly
isfreeaccess_txt	false
familylinks_str_mv	(DE-627)373977859 (DE-600)2127607-9
title	VEGFR-1 antagonists and PlGF have great therapeutic potential
ctrlnum	(DE-627)SPR03513786X (SPR)00128413-200213540-00013-e
title_full	VEGFR-1 antagonists and PlGF have great therapeutic potential
journal	Inpharma weekly
journalStr	Inpharma weekly
lang_code	eng
isOA_bool	false
recordtype	marc
publishDateSort	2002
contenttype_str_mv	txt
container_start_page	7
container_volume	1354
format_se	Elektronische Aufsätze
doi_str_mv	10.2165/00128413-200213540-00013
title_sort	vegfr-1 antagonists and plgf have great therapeutic potential
title_auth	VEGFR-1 antagonists and PlGF have great therapeutic potential
abstract	© Adis International Ltd 2002
abstractGer	© Adis International Ltd 2002
abstract_unstemmed	© Adis International Ltd 2002
collection_details	GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20
container_issue	1
title_short	VEGFR-1 antagonists and PlGF have great therapeutic potential
url	https://dx.doi.org/10.2165/00128413-200213540-00013
remote_bool	true
ppnlink	373977859
mediatype_str_mv	c
isOA_txt	false
hochschulschrift_bool	false
doi_str	10.2165/00128413-200213540-00013
up_date	2024-07-03T13:43:23.894Z
_version_	1803565613864452096
fullrecord_marcxml	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">SPR03513786X</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230519203420.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">201007s2002 xx \|\|\|\|\|o 00\| \|\|eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.2165/00128413-200213540-00013</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)SPR03513786X</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(SPR)00128413-200213540-00013-e</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">VEGFR-1 antagonists and PlGF have great therapeutic potential</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2002</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">© Adis International Ltd 2002</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Vascular Endothelial Growth Factor</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Vascular Endothelial Growth Factor Expression</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Bone Marrow Suppression</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Haematopoietic Stem Cell</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Nature Medicine</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">Inpharma weekly</subfield><subfield code="d">Auckland : ADIS internat., 1975</subfield><subfield code="g">1354(2002), 1 vom: Sept., Seite 7-7</subfield><subfield code="w">(DE-627)373977859</subfield><subfield code="w">(DE-600)2127607-9</subfield><subfield code="x">2230-6056</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:1354</subfield><subfield code="g">year:2002</subfield><subfield code="g">number:1</subfield><subfield code="g">month:09</subfield><subfield code="g">pages:7-7</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://dx.doi.org/10.2165/00128413-200213540-00013</subfield><subfield code="z">lizenzpflichtig</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_SPRINGER</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">1354</subfield><subfield code="j">2002</subfield><subfield code="e">1</subfield><subfield code="c">09</subfield><subfield code="h">7-7</subfield></datafield></record></collection>
score	7.4008465

Nicht das Richtige dabei?

Schreiben Sie uns!

VEGFR-1 antagonists and PlGF have great therapeutic potential

Nicht das Richtige dabei?

Zugang & Verfügbarkeit

Vorhandene Bände

Nicht das Richtige dabei?